| 08/18 | DJ | Correction to Biogen Treads Tricky Path Between Politicians, Investors Articl.. |
| 08/18 | | ROCHE : New target could yield treatment for Alzheimer`s, ALS and more |
| 08/17 | | ROCHE : Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Cla.. |
| 08/16 | | FIBROGEN : Galapagos and FibroGen drugs offer hope in IPF |
| 08/16 | | FOUNDATION MEDICINE : Cancer Treatment Centers of America and Foundation Medicin.. |
| 08/15 | | ROCHE : Acquires MySugr |
| 08/15 | | CHUGAI PHARMACEUTICAL : Announcement of a Commencement of Arbitration against Ch.. |
| 08/15 | DJ | ROCHE : Drug-Trial Previews Burn Investors -- WSJ |
| 08/14 | | ROCHE : Special Notice - 66-- Intent to Sole Source / Roche Diagnostics Corporat.. |
| 08/14 | DJ | ROCHE : Some Investors Feel Burned by Drugmakers' Clinical-Trial Reports |
| 08/12 | | ROCHE : KIT, solution and material, compatible with use in blood and PH hemogaso.. |
| 08/11 | | ESSEX BIO TECHNOLOGY : Ac immune reports second quarter 2017 financial results |
| 08/11 | | INSIDER TRADING ACTIVITY FOUNDATION : FMI) – Director Sold 30,000 shares .. |
| 08/11 | | INSIDER TRADING ACTIVITY FOUNDATION : FMI) – Insider Sold 46,872 shares o.. |
| 08/11 | | INSIDER TRADING ACTIVITY FOUNDATION : FMI) – Director Sold 4,800 shares o.. |
| 08/10 | | Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit aga.. |
| 08/10 | | Khang & Khang LLP Announces Securities Class Action Lawsuit against Foundatio.. |
| 08/10 | | ROCHE : Clinical Nurse Leader Concentration Added to La Roche's MSN Program |
| 08/10 | | ROCHE : Daiichi`s Plexxikon goes after Novartis cancer med Tafinlar in BRAF pate.. |
| 08/10 | | Roche out-licenses lebrikizumab rights to Dermira |
| 08/10 | | ROCHE : Analysis services |
| 08/09 | | ROCHE : A better life in Cornwall |
| 08/09 | | DERMIRA : Gains Rights to Roche IL-13 Inhibitor Lebrikizumab in Up-to-$1.4B Part.. |
| 08/09 | | ROCHE : sells off its struggling IL-13 drug lebrikizumab in $1.4B Dermira deal |
| 08/09 | | INSIDER TRADING ACTIVITY FOUNDATION : FMI) – Director Sold 18,072 shares .. |
| 08/08 | | ROCHE : Genentech - FDA Grants Priority Review and Breakthrough Therapy Designat.. |
| 08/08 | | DERMIRA, INC. (NASDAQ : DERM) Files An 8-K Entry into a Material Definitive Agre.. |
| 08/08 | | NATCO PHARMA : NET UP AT Rs93.7 CRORE |
| 08/08 | | FOUNDATION MEDICINE : $-0.17 EPS Expected for Universal Business Payment Solutio.. |
| 08/08 | | ROCHE : FDA Grants Priority Review and Breakthrough Therapy Designation for Zelb.. |
| 08/07 | | ROCHE HOLDING LTD. : DEADLINE TODAY: Khang & Khang LLP Announces Securities Clas.. |
| 08/07 | | ROCHE HOLDING LTD. : DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders .. |
| 08/07 | | ROCHE HOLDING LTD. : FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Re.. |
| 08/07 | | ROCHE : FDA Grants Priority Review and Breakthrough Therapy Designation for Zelb.. |
| 08/05 | | ROCHE HOLDING LTD. : DEADLINE MONDAY: Lundin Law PC Announces Securities Class A.. |
| 08/04 | | ROCHE : Insurance services |
| 08/04 | | ROCHE HOLDING LTD. : RHHBY DEADLINE ALERT: The Law Offices of Vincent Wong Remin.. |
| 08/04 | | ROCHE : working to identify treatment options for lung cancer patients |
| 08/04 | | ROCHE : UK NICE invites Roche to submit Cancer Drugs Fund proposal for atezolizu.. |
| 08/04 | | ROCHE : UKs NICE invites Roche to submit CDF proposal for urothelial cancer drug |
| 08/04 | | ROCHE : NICE invites Roche to submit Tecentriq for CDF |
| 08/04 | | ROCHE : Genentech - FDA Grants Genentech's Alecensa Priority Review for Initial .. |
| 08/04 | | ROCHE : Refuse and waste related services |
| 08/03 | | ROCHE HOLDING LTD. : 4-DAY DEADLINE: Khang & Khang LLP Announces Securities Clas.. |
| 08/03 | | ACCENTURE : to Transform Diabetic Patient Care Using Data-driven Analytics Platf.. |
| 08/03 | | FOUNDATION MEDICINE : Findings from Foundation Medicine Inc. in Oncology Reporte.. |
| 08/03 | | SEATTLE GENETICS : Announces Clinical Collaboration to Expand the Therapeutic Ev.. |
| 08/03 | | ROCHE HOLDING LTD. : The Klein Law Firm Reminds Investors of a Class Action File.. |
| 08/03 | | HOW NOVARTIS AG (ADR) (NYSE : NVS) Uses Proceeds From Asset Sales Would Determin.. |
| 08/03 | | ROCHE : NICE - Share, Roche invited to submit a CDF proposal for urothelial canc.. |
| 08/03 | | ROCHE : Theravance Biopharma Appoints Shehnaaz Suliman, MD, as Senior Vice Presi.. |
| 08/03 | | ROCHE : FDA grants Roche’s Alecensa Priority Review for initial treatment .. |
| 08/03 | | ROCHE : FDA Grants Genentech’s Alecensa Priority Review for Initial Treatm.. |
| 08/02 | | ROCHE HOLDING LTD. : Levi & Korsinsky, LLP Reminds Shareholders of Roche Holding.. |
| 08/01 | | FOUNDATION MEDICINE : reports 2Q loss |
| 08/01 | | FOUNDATION MEDICINE, INC. (NASDAQ : FMI) Files An 8-K Entry into a Material Defi.. |
| 08/01 | | FOUNDATION MEDICINE, INC. : Entry into a Material Definitive Agreement, Results .. |
| 08/01 | | ROCHE : to showcase power of connected lab at AACC 2017 Clinical Lab Expo |
| 07/30 | | ROCHE : CRICKET-YODI-SCOREBOARD Zimbabwe U19s vs Windies U19s - 3rd game |
| 07/29 | | ROCHE : Sausage products |
| 07/28 | | SENSEONICS : Roche partners with Senseonics, TypeZero on artificial pancreas |
| 07/28 | | ROCHE : FDA grants breakthrough therapy designation for Venclexta in acute myelo.. |
| 07/28 | | ROCHE : raises outlook for 2017 following strong launches |
| 07/27 | | CHUGAI PHARMACEUTICAL REPORTS FINDIN : their identification and pharmacological .. |
| 07/27 | | ROCHE HOLDING LTD. : UPCOMING DEADLINE: Lundin Law PC Announces Securities Class.. |
| 07/27 | | ROCHE HOLDING LTD. : Levi & Korsinsky, LLP Reminds Shareholders of Roche Holding.. |
| 07/27 | | ROCHE : antibody becomes first of its kind authorised for blood cancer |
| 07/27 | | SENSEONICS : Roche joins quest to create closed loop insulin device |
| 07/27 | | AstraZeneca slump dominates European shares on busy earnings day |
| 07/27 | | ROCHE : NICE backs Cancer Drugs Fund support for Roche`s Gazyvaro |
| 07/27 | | ROCHE : reports strong performance in the first half of 2017 |
| 07/26 | | ROCHE : Positive Phase III Results of Genentech’s Actemra (Tocilizumab) fo.. |
| 07/26 | | ROCHE HOLDING LTD. : DEADLINE ALERT: Khang & Khang LLP Announces Securities Clas.. |
| 07/26 | | ROCHE HOLDING LTD. : RHHBY The Law Offices of Vincent Wong Reminds Investors of .. |
| 07/26 | | ROCHE HOLDING LTD. : DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds .. |
United Kingdom
France
Deutschland
Schweiz (DE)
